Anixa Biosciences reports patient survival data from cancer therapy trial

May 11, 2026 8:55 AM

Anixa Biosciences Inc. (NASDAQ: ANIX) reported survival data from its ongoing Phase 1 clinical trial of lira-cel, a CAR-T therapy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found